CHLORPHENTERMINE S.A. IN THE TREATMENT OF OBESITY AND THE EFFECT OF WEIGHT LOSS ON STEROID EXCRETION.
作者信息
JACKSON I M, WHYTE W G
出版信息
Br Med J. 1965 Aug 21;2(5459):453-5. doi: 10.1136/bmj.2.5459.453.
Abstract
摘要
相似文献
1
CHLORPHENTERMINE S.A. IN THE TREATMENT OF OBESITY AND THE EFFECT OF WEIGHT LOSS ON STEROID EXCRETION.
Br Med J. 1965 Aug 21;2(5459):453-5. doi: 10.1136/bmj.2.5459.453.
2
CURRENT THERAPEUTICS. 203. SUSTAINED-ACTION CHLORPHENTERMINE IN THE CORRECTION OF REFRACTORY OBESITY.
Practitioner. 1964 Nov;193:698-702.
3
OBESITY TREATMENT OF COMPLICATED AND UNCOMPLICATED CASES WITH CHLORPHENTERMINE HYDROCHLORIDE.
Ind Med Surg. 1965 Jun;34:490-2.
4
[EFFECT OF PHENYLACETIC ACID ON URINARY EXCRETION OF 17-HYDROXYCORTICOSTEROIDS, 17-KETOSTEROIDS AND 17-KETOGENIC STEROIDS].
Endokrynol Pol. 1964 Jan-Feb;15:89-99.
5
17-Ketogenic steroid excretion in obese children before and after weight reduction.
Br Med J. 1958 Mar 22;1(5072):686-8. doi: 10.1136/bmj.1.5072.686.
6
[CLINICAL STUDY OF AN ANOREXIGEN WITH PROLONGED EFFECT (S 62-2-CHLORPHENTERMINE) (APROPOS OF 30 OBSERVATIONS)].
Ann Med Nancy. 1964 Dec;3:1485-91.
7
8
EFFECTS OF MULTIPLE INFUSIONS OF A FAT EMULSION ON BLOOD COAGULATION, LIVER FUNCTION AND URINARY EXCRETION OF STEROIDS IN SCHIZOPHRENIC PATIENTS.
Am J Clin Nutr. 1965 Jan;16:156-64. doi: 10.1093/ajcn/16.1.156.
9
10
EFFECTS OF A BACTERIAL PYROGEN ON THE ELIMINATION OF URINARY 17-HYDROXYCORTICOSTEROIDS IN NORMAL SUBJECTS.
J Clin Endocrinol Metab. 1965 Jan;25:17-9. doi: 10.1210/jcem-25-1-17.
引用本文的文献
1
Update on Pediatric Anti-obesity Medications-Current Landscape and Approach to Prescribing.
Curr Obes Rep. 2024 Jun;13(2):295-312. doi: 10.1007/s13679-024-00566-z. Epub 2024 Apr 30.
2
Neurochemical regulators of food behavior for pharmacological treatment of obesity: current status and future prospects.
Future Med Chem. 2020 Oct;12(20):1865-1884. doi: 10.4155/fmc-2019-0361. Epub 2020 Oct 12.
本文引用的文献
1
Status and prospect of drugs for overeating.
JAMA. 1960 Jul 9;173:1131-6. doi: 10.1001/jama.1960.73020280008015.
2
CURRENT THERAPEUTICS. 203. SUSTAINED-ACTION CHLORPHENTERMINE IN THE CORRECTION OF REFRACTORY OBESITY.
Practitioner. 1964 Nov;193:698-702.
3
DIFFERENTIAL DIAGNOSIS OF CUSHING'S SYNDROME AND OBESITY ASSOCIATED WITH STRIAE.
Lancet. 1964 Nov 21;2(7369):1079-82. doi: 10.1016/s0140-6736(64)92606-6.
4
Chlorphentermine: a new "appetite suppressant". A cross-over double-blind trial.
Ulster Med J. 1962 Dec 1;31(2):181-4.
5
Chlorphentermine in the management of obesity.
Practitioner. 1963 Jul;191:65-9.
6
Phenmetrazine hydrochloride and methylcellulose in the treatment of "refractory" obesity.
Lancet. 1960 Jun 11;1(7137):1262-5. doi: 10.1016/s0140-6736(60)92249-2.
7
Pharmacology of a series of nuclear substituted phenyltertiary-butylamines with particular reference to anorexigenic and central stimulating properties.
Acta Pharmacol Toxicol (Copenh). 1960;17:121-36. doi: 10.1111/j.1600-0773.1960.tb01236.x.
Zotero 插件